Matthew Tollefson

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. doi request reprint Blood type, lymphadenectomy and blood transfusion predict venous thromboembolic events following radical prostatectomy with pelvic lymphadenectomy
    Matthew K Tollefson
    Departments of Urology and Health Sciences Research LR, RC, Mayo Medical School and Mayo Clinic, Rochester, Minnesota Electronic address
    J Urol 191:646-51. 2014
  2. doi request reprint The impact of clinical stage on prostate cancer survival following radical prostatectomy
    Matthew K Tollefson
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA
    J Urol 189:1707-12. 2013
  3. doi request reprint Downstaging to non-invasive urothelial carcinoma is associated with improved outcome following radical cystectomy for patients with cT2 disease
    Matthew K Tollefson
    Department of Urology, Mayo Medical School and Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA
    World J Urol 30:795-9. 2012
  4. doi request reprint Lifelong yearly prostate specific antigen surveillance is not necessary for low risk prostate cancer treated with radical prostatectomy
    Matthew K Tollefson
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA
    J Urol 184:925-9. 2010
  5. doi request reprint Raman spectral imaging of prostate cancer: can Raman molecular imaging be used to augment standard histopathology?
    Matthew Tollefson
    Mayo Clinic and Mayo Medical School, Rochester, MN 55905, USA
    BJU Int 106:484-8. 2010
  6. doi request reprint Robotic-assisted radical prostatectomy decreases the incidence and morbidity of surgical site infections
    Matthew K Tollefson
    Department of Urology, Mayo Medical School, Rochester, MN, USA
    Urology 78:827-31. 2011
  7. doi request reprint Surgical treatment of renal cell carcinoma in the immunocompromised transplant patient
    Matthew K Tollefson
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA
    Urology 75:1373-7. 2010
  8. ncbi request reprint Contemporary imaging modalities for the surveillance of patients with renal cell carcinoma
    Matthew K Tollefson
    Department of Urology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Curr Urol Rep 8:38-43. 2007
  9. doi request reprint Administrative data sets are inaccurate for assessing functional outcomes after radical prostatectomy
    Matthew K Tollefson
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA
    J Urol 185:1686-90. 2011
  10. ncbi request reprint Stratification of patient risk based on prostate-specific antigen doubling time after radical retropubic prostatectomy
    Matthew K Tollefson
    Department of Urology, College of Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Mayo Clin Proc 82:422-7. 2007

Detail Information

Publications19

  1. doi request reprint Blood type, lymphadenectomy and blood transfusion predict venous thromboembolic events following radical prostatectomy with pelvic lymphadenectomy
    Matthew K Tollefson
    Departments of Urology and Health Sciences Research LR, RC, Mayo Medical School and Mayo Clinic, Rochester, Minnesota Electronic address
    J Urol 191:646-51. 2014
    ..To identify venous thromboembolic event risk factors and, thereby, facilitate targeted prophylaxis we characterized clinicopathological variables associated with these events in patients undergoing radical prostatectomy...
  2. doi request reprint The impact of clinical stage on prostate cancer survival following radical prostatectomy
    Matthew K Tollefson
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA
    J Urol 189:1707-12. 2013
    ..In this study we evaluated the association of clinical stage with death from prostate cancer in men who underwent radical prostatectomy and assessed for changes in its prognostic value over time...
  3. doi request reprint Downstaging to non-invasive urothelial carcinoma is associated with improved outcome following radical cystectomy for patients with cT2 disease
    Matthew K Tollefson
    Department of Urology, Mayo Medical School and Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA
    World J Urol 30:795-9. 2012
    ..Therefore, we reviewed the long-term outcomes in patients who were downstaged to non-invasive urothelial carcinoma at time of RC...
  4. doi request reprint Lifelong yearly prostate specific antigen surveillance is not necessary for low risk prostate cancer treated with radical prostatectomy
    Matthew K Tollefson
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA
    J Urol 184:925-9. 2010
    ..In this study we investigate the need for yearly prostate specific antigen measurements in patients with surgically treated low risk prostate cancer...
  5. doi request reprint Raman spectral imaging of prostate cancer: can Raman molecular imaging be used to augment standard histopathology?
    Matthew Tollefson
    Mayo Clinic and Mayo Medical School, Rochester, MN 55905, USA
    BJU Int 106:484-8. 2010
    ....
  6. doi request reprint Robotic-assisted radical prostatectomy decreases the incidence and morbidity of surgical site infections
    Matthew K Tollefson
    Department of Urology, Mayo Medical School, Rochester, MN, USA
    Urology 78:827-31. 2011
    ..However, existing comparisons between open and robotic surgery have been made comparing a contemporary robotic experience with historical cohorts undergoing open surgery...
  7. doi request reprint Surgical treatment of renal cell carcinoma in the immunocompromised transplant patient
    Matthew K Tollefson
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA
    Urology 75:1373-7. 2010
    ..To determine whether iatrogenic immunosuppression used after transplantation infers a poor prognosis of renal cell carcinoma (RCC) as natural negative immune regulators have been associated with decreased cancer-specific survival from RCC...
  8. ncbi request reprint Contemporary imaging modalities for the surveillance of patients with renal cell carcinoma
    Matthew K Tollefson
    Department of Urology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Curr Urol Rep 8:38-43. 2007
    ..Herein we review the relevance of these modalities to the follow-up of patients with renal cell carcinoma...
  9. doi request reprint Administrative data sets are inaccurate for assessing functional outcomes after radical prostatectomy
    Matthew K Tollefson
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA
    J Urol 185:1686-90. 2011
    ..Therefore, we determined the prognostic value of administrative claims data for reporting urinary incontinence and erectile dysfunction after radical prostatectomy...
  10. ncbi request reprint Stratification of patient risk based on prostate-specific antigen doubling time after radical retropubic prostatectomy
    Matthew K Tollefson
    Department of Urology, College of Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Mayo Clin Proc 82:422-7. 2007
    ....
  11. doi request reprint Radical prostatectomy for prostate cancer after ileal pouch-anal anastomosis offers oncologic control and sustains quality of life
    Eric C Umbreit
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, MN, USA
    J Am Coll Surg 210:232-9. 2010
    ..We evaluated the feasibility and oncologic durability of performing prostate biopsy and open radical retropubic prostatectomy (RRP) in patients who have previously undergone proctocolectomy and ileal pouch-anal anastomosis (PC-IPAA)...
  12. doi request reprint Long-term complications of conduit urinary diversion
    Mark S Shimko
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota, USA
    J Urol 185:562-7. 2011
    ..We evaluated long-term surgical complications and clinical outcomes in a large group of patients treated with conduit urinary diversion...
  13. ncbi request reprint Ki-67 and coagulative tumor necrosis are independent predictors of poor outcome for patients with clear cell renal cell carcinoma and not surrogates for each other
    Matthew K Tollefson
    Department of Urology, Mayo Clinic and Mayo Medical School, Rochester, MN 55905, USA
    Cancer 110:783-90. 2007
    ..Thus, the goal was to directly test whether Ki-67 and necrosis convey similar or distinct information for the prognostic assessment of ccRCC...
  14. ncbi request reprint Long-term prognostic significance of primary Gleason pattern in patients with Gleason score 7 prostate cancer: impact on prostate cancer specific survival
    Matthew K Tollefson
    Department of Urology, Mayo Clinic, Rochester, Minnesota, USA
    J Urol 175:547-51. 2006
    ..We determined the long-term clinical significance of primary Gleason pattern in patients with Gleason score 7 prostate cancer...
  15. ncbi request reprint In situ partial nephrectomy and tumor thrombectomy for renal cell carcinoma with level II vena cava extension in a solitary kidney
    Matthew K Tollefson
    Department of Urology, Mayo Clinic, Rochester, Minnesota 55901, USA
    Urology 66:882. 2005
    ..Accessory renal veins were identified preoperatively using a three-dimensional, multidetector row computed tomography scan and preserved intraoperatively, allowing complete oncologic resection without compromising renal function...
  16. doi request reprint Significance of distal ureteral margin at radical cystectomy for urothelial carcinoma
    Matthew K Tollefson
    Department of Urology and Health Sciences Research, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA
    J Urol 183:81-6. 2010
    ..Management of the distal ureter at cystectomy remains controversial and the impact of a sequential sectioning strategy remains unclear...
  17. doi request reprint The effect of Gleason score on the predictive value of prostate-specific antigen doubling time
    Matthew K Tollefson
    Department of Urology, Mayo Clinic, Rochester, MN 55905, USA
    BJU Int 105:1381-5. 2010
    ....
  18. pmc Meckel diverticulum: the Mayo Clinic experience with 1476 patients (1950-2002)
    John J Park
    Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, MN 55905, USA
    Ann Surg 241:529-33. 2005
    ..Through a comprehensive review of the Mayo Clinic experience with patients who had Meckel diverticulum, we sought to determine which diverticula should be removed when discovered incidentally during abdominal surgery...
  19. ncbi request reprint Intraductal papillary mucinous neoplasm: did it exist prior to 1980?
    Matthew K Tollefson
    Department of Surgery, Mayo Clinic, Rochester, MN 55905, USA
    Pancreas 26:e55-8. 2003
    ..Intraductal papillary mucinous neoplasm (IPMN) of the pancreas was first reported in 1982. It is not clear whether the appearance of this neoplasm is a new epidemic or an old disease previously overlooked...